Thu, November 17, 2022
Wed, November 16, 2022
Tue, November 15, 2022
Mon, November 14, 2022
Fri, November 11, 2022

Larry Biegelsen Upgraded (TNDM) to Hold and Held Target at $43 on, Nov 15th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. hold-and-held-target-at-43-on-nov-15th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Larry Biegelsen of Wells Fargo, Upgraded "Tandem Diabetes Care, Inc." (TNDM) to Hold and Held Target at $43 on, Nov 15th, 2022.

Larry has made no other calls on TNDM in the last 4 months.



There are 5 other peers that have a rating on TNDM. Out of the 5 peers that are also analyzing TNDM, 0 agree with Larry's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Larry


  • Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $52 on, Friday, November 4th, 2022
  • Matt O'Brien of "Piper Sandler" Maintained at Buy with Decreased Target to $70 on, Thursday, November 3rd, 2022
  • Matt Miksic of "Barclays" Initiated at Buy and Held Target at $75 on, Tuesday, October 18th, 2022
  • Matthew Taylor of "Jefferies" Initiated at Strong Buy and Held Target at $75 on, Wednesday, October 12th, 2022
  • Lawrence Biegelsen of "Wells Fargo" Maintained at Buy with Decreased Target to $82 on, Thursday, August 4th, 2022